デフォルト表紙
市場調査レポート
商品コード
1373829

バイオニックアイの世界市場 - 市場規模、シェア、成長分析:タイプ別、技術別 - 業界予測(2023年~2030年)

Global Bionic Eye Market Size, Share, Growth Analysis, By Type(External eye and implanted eye), By Technology(Electronic and mechanical) - Industry Forecast 2023-2030

出版日: | 発行: SkyQuest | ページ情報: 英文 157 Pages | 納期: 3~5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
バイオニックアイの世界市場 - 市場規模、シェア、成長分析:タイプ別、技術別 - 業界予測(2023年~2030年)
出版日: 2023年10月17日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 目次
概要

世界のバイオニックアイの市場規模は、2021年に2億3,662万米ドル、2022年に2億6,710万米ドルとなりました。同市場は、予測期間中(2023年~2030年)に12.88%のCAGRで拡大し、2030年には7億406万米ドルに成長する見通しです。

世界のバイオニックアイ市場は、視力回復技術の分野で大きな成長と進歩を遂げています。市場を牽引しているのは、網膜疾患の有病率の増加、高齢者人口の増加、バイオニックアイ技術の進歩といった要因です。網膜疾患を患う人の増加により、視力を回復または強化できる革新的なソリューションに対する大きな需要が生じています。さらに、高齢化社会は視力に関連した疾患にかかりやすく、市場の成長にさらに貢献しています。技術の進歩により、より高度で効果的なバイオニックアイシステムが開発されています。これらのシステムは通常、網膜の残存機能細胞を刺激する移植可能な装置と、外部カメラおよび画像処理ユニットで構成されています。継続的な研究開発の努力は、バイオニックアイの解像度、視力、全体的な性能を向上させ、より質の高い視力を患者に提供することに集中しています。しかし、世界のバイオニックアイ市場はいくつかの課題にも直面しています。主な課題の1つは、バイオニックアイ・インプラントと関連する外科手術に関連する高コストです。このコストは、特に発展途上国やヘルスケア・インフラが不十分な地域において、より多くの人々がこれらの機器にアクセスすることを制限する可能性があります。

網膜色素変性症や加齢黄斑変性症などの網膜疾患の罹患率の上昇は、世界のバイオニックアイ市場の重要な促進要因です。網膜疾患により重度の視力障害や失明を患う人が増加するにつれて、視力回復ソリューションとしてのバイオニックアイ技術に対する需要が高まっています。

電極アレイ、画像処理アルゴリズム、無線通信の改良など、バイオニックアイ技術の継続的な進歩が市場を牽引しています。これらの技術革新は、視力、解像度、バイオニックアイの全体的な性能を向上させ、患者により良い結果をもたらすことを目指しています。

当レポートは、世界のバイオニックアイ市場について調査し、市場の概要とともに、タイプ別、技術別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

エグゼクティブサマリー

親市場分析

市場規模

  • 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題

主要な市場の洞察

  • 技術分析
  • 価格分析
  • サプライチェーン分析
  • バリューチェーン分析
  • 市場のエコシステム
  • IP分析
  • 動向分析
  • スタートアップ分析
  • 原材料分析
  • イノベーションマトリックス
  • パイプライン製品分析
  • マクロ経済指標
  • トップ投資分析
  • 主な成功要因
  • 競合の程度

市場力学と見通し

  • 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
  • 規制状況
  • ポーター分析

世界のバイオニックアイ市場、タイプ別

  • 市場概要
  • 外眼、移植眼

世界のバイオニックアイ市場、技術別

  • 市場概要
  • 電子的、機械的

世界のバイオニックアイ市場、地域別

  • 市場概要
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

競合情勢

  • 主要企業プロファイル
    • Second Sight Medical Products, Inc.
    • Retina Implant AG
    • Pixium Vision
    • Bionic Vision Technologies Pty Ltd
    • Nano Retina Ltd
    • iBIONICS
    • The Chicago Eye and Ear Infirmary
    • Bionic Eye Technologies
    • Monash Vision Group
    • Intelligent Implants GmbH
    • Boston Retinal Implant Project
    • Johns Hopkins University School of Medicine
    • Okuvision GmbH
    • University of Southern California
    • University of California, Los Angeles (UCLA)
    • Moorfields Eye Hospital NHS Foundation Trust
    • Centre for Eye Research Australia
    • Advanced Bionics AG
    • Stanford University
    • University of Pittsburgh Medical Center (UPMC)
目次
Product Code: SQMIG35H2113

Global Bionic Eye Market size was valued at USD 236.62 Million in 2021 and is poised to grow from USD 267.1 Million in 2022 to USD 704.06 Million by 2030, at a CAGR of 12.88% during the forecast period (2023-2030).

The global bionic eye market is experiencing significant growth and advancements in the field of vision restoration technology. The market is being driven by factors such as the increasing prevalence of retinal diseases, a rising geriatric population, and advancements in bionic eye technology. The growing number of individuals suffering from retinal disorders creates a substantial demand for innovative solutions that can restore or enhance their vision. Additionally, the aging population is prone to vision-related conditions, further contributing to the market growth. Technological advancements have led to the development of more sophisticated and effective bionic eye systems. These systems typically consist of an implantable device that stimulates the remaining functional cells of the retina, coupled with an external camera and image processing unit. Continuous research and development efforts are focused on improving the resolution, visual acuity, and overall performance of bionic eyes, offering patients a better quality of vision. However, the global bionic eye market also faces several challenges. One of the primary challenges is the high cost associated with bionic eye implants and the related surgical procedures. The cost can limit the accessibility of these devices to a wider population, particularly in developing countries or regions with inadequate healthcare infrastructure.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Emergency Lighting Systems Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bionic Eye Market Segmental Analysis

The global bionic eye market is segmented on the basis of type, technology, and region. By type, the market is segmented into external eye, and implanted eye. By technology, the market is segmented into electronic and mechanical. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Bionic Eye Market Dynamics

Drivers of the Global Bionic Eye Market

Increasing Prevalence of Retinal Diseases

The rising incidence of retinal diseases, such as retinitis pigmentosa and age-related macular degeneration, is a significant driver of the global bionic eye market. As the number of individuals with severe vision impairments or blindness due to retinal diseases increases, the demand for bionic eye technology as a vision restoration solution grows.

Advancements in Bionic Eye Technology

Ongoing advancements in bionic eye technology, including improvements in electrode arrays, image processing algorithms, and wireless communication, are driving the market. These technological innovations aim to enhance visual acuity, resolution, and overall performance of bionic eyes, offering better outcomes for patients.

Restraints in the Global Bionic Eye Market

High Cost of Bionic Eye Implants

The cost associated with bionic eye implants and related surgical procedures can be a significant barrier to market growth. The high cost of these devices limits their accessibility, particularly in regions with inadequate healthcare infrastructure or where reimbursement coverage is limited. Affordability and reimbursement challenges hinder the adoption of bionic eye technology.

Limited Awareness and Education

Despite technological advancements, there is still a lack of awareness and understanding among patients and healthcare professionals about the potential benefits and availability of bionic eye technology. Limited awareness can result in delayed or underutilised adoption of bionic eyes, thereby restraining market growth.

Market Trends of Global Bionic Eye Key

Miniaturisation and Implantable Designs

There is a growing trend towards miniaturisation of bionic eye devices, making them more compact and implantable. Smaller and more discreet designs allow for easier surgical implantation and improved patient comfort. The development of implantable bionic eyes with wireless power and data transmission systems is also gaining traction.

Integration with External Devices and Connectivity

Bionic eyes are increasingly being developed to integrate with external devices and systems. This includes integration with glasses, virtual reality headsets, or smartphone applications, allowing for enhanced visual perception and interaction with the environment. Connectivity features enable real-time updates, remote monitoring, and customization of bionic eye settings.

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
    • Regulatory Landscape
    • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Bionic Eye Market by Type
    • Market Overview
    • External eye and implanted eye
  • Global Bionic Eye Market by Technology
    • Market Overview
    • Electronic and mechanical
  • Global Bionic Eye Market Size by Region
    • Market Overview
    • North America
  • USA
  • Canada
    • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
    • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
    • Latin America
  • Brazil
  • Rest of Latin America
    • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
  • By Development
  • By Company
  • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • Second Sight Medical Products, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Retina Implant AG - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Pixium Vision - France
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Bionic Vision Technologies Pty Ltd - Australia
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Nano Retina Ltd. - Israel
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • iBIONICS - Canada
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • The Chicago Eye and Ear Infirmary (The University of Illinois Hospital & Health Sciences System) - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Bionic Eye Technologies - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Monash Vision Group - Australia
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Intelligent Implants GmbH - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Boston Retinal Implant Project - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Johns Hopkins University School of Medicine - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Okuvision GmbH - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • University of Southern California - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • University of California, Los Angeles (UCLA) - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Moorfields Eye Hospital NHS Foundation Trust - UK
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Centre for Eye Research Australia - Australia
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Advanced Bionics AG - Switzerland
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Stanford University - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • University of Pittsburgh Medical Center (UPMC) - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments